Skip to content

Comparison the efficacy of lavender aroma and valerian in reducing labor pain and Progress of labor in nulliparous women

Comparison the efficacy of lavender aroma and valerian in reducing labor pain and Progress of labor in nulliparous women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201504236582N10
Enrollment
141
Registered
2015-05-30
Start date
2015-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor pain. Other specified assisted single delivery

Interventions

Intervention 1: In Lavender group in dilatations 4
every hour, 3 drops of lavender aroma (Glass labeled 1) Drops on a cotton ball and the patient will be close to their nose and smell it for 10 minutes. Intervention 2: In valerian group in dilatations
every hour, 3 drops of valerian aroma (Glass labeled 2) Drops on a cotton ball and the patient will be close to their nose and smell it for 10 minutes of every hour. Intervention 3: In Olive oil group
every hour, 3 drops of Olive oil aroma (Glass labeled 3) Drops on a cotton ball and the patient will be close to their nose and smell it for 10 minutes.
Treatment - Drugs
In Lavender group in dilatations 4
every hour, 3 drops of lavender aroma (Glass labeled 1) Drops on a cotton ball and the patient will be close to their nose and smell it for 10 minutes.
In valerian group in dilatations 4 cm
every hour, 3 drops of valerian aroma (Glass labeled 2) Drops on a cotton ball and the patient will be close to their nose and smell it for 10 minutes of every hour.
In Olive oil group in dilatations 4

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Primiparous pregnancy; age 18-35; gestational age of 37-41 w; singleton fetus; active phase; cephalic presentation; no smoking; no addiction; no Lack of vision; no history of chronic heart diseases, lung diseases, according to the patient's expression; the absence of eclampsia; and placenta previa; no PROM for more than 18 hours; no history of infertility; willingness to participate in the study; no history of sensitivity; the presence of low-risk pregnancies. Exclusion Criteria: Get analgesic medication during the 3 hours before the start of the study; systolic blood pressure less than 95 mm Hg.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intensity of labor pain. Timepoint: before intervention, 6-8-10cm of cervix dilatasion. Method of measurement: VAS (Visual Analog Scale).

Secondary

MeasureTime frame
The duration of the active phase. Timepoint: each 2 hour. Method of measurement: vaginal examination.;Duration of the second stage of labor. Timepoint: from full dilatasion until lTime of Birth. Method of measurement: Questionnaire.;Neonatal outcomes (The first and fifth minute Apgar scores and Refer to the NICU). Timepoint: After birth. Method of measurement: Questionnaire.;Type of delivery. Timepoint: After birth. Method of measurement: Questionnaire.;Side effects (Nausea and vomiting). Timepoint: During the study. Method of measurement: cheklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahin Kamalifard

Tabriz University of Medical Sciences

kamalifardm@tbzmed.ac.ir+98 41 3479 6770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026